Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TCTR20140224006Not yet recruiting
Trial of hydroxyprogesterone caproate in menopause, sponsored by Chiang Mai University. Primary endpoint: Primary sleep quality outcome. Planned start Mar 2014; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on TCTR20140224006.